Top Sell
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novan Inc | 0 | 24 | 0 | 1 | €0.001 | - | - |
| Moleculin Biotech Inc | 3 | 27 | 0 | 1 | €0.41 | €18.42 | 4393.659% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 16 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 475.113% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.15 | €7.00 | 13.821% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.77 | €6.53 | 750.945% |
| Applied Therapeutics Inc | 1 | 1 | 0 | 0 | €4.00 | €4.00 | 0.000% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €2.83 | - | - |
| Sage Therapeutics Inc. | 4 | 3 | 0 | 0 | €12.78 | €43.36 | 239.393% |
| D.Western Therapeutics Institute Inc | 1 | 1 | 0 | 0 | €0.51 | €1.70 | 233.333% |
| Fibrogen Inc. | 1 | 4 | 0 | 0 | €0.95 | €0.000 | -100.000% |
| Nymox Pharmaceutical Corp. | 0 | 3 | 0 | 0 | €0.23 | - | - |
| Cyclacel Pharmaceuticals Inc. | 1 | 13 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
| Incyte Corp. | 10 | 2 | 1 | 0 | €48.29 | €78.59 | 62.747% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €28.28 | €38.00 | 34.387% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.65 | €3.00 | 363.106% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.00 | €3.65 | 265.998% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 0 | €0.94 | €3.00 | 219.149% |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €29.93 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.38 | €7.00 | 194.118% |
| AEterna Zentaris Inc. | 3 | 20 | 0 | 0 | €1.85 | €14.02 | 657.865% |
| Formycon AG | 3 | 1 | 0 | 0 | €39.75 | €100.00 | 151.572% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.40 | €15.50 | 25.052% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 0 | €1.35 | €5.10 | 278.019% |
| CytoTools AG | 0 | 1 | 0 | 0 | €0.54 | - | - |